Cargando…
Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance
Previous studies have reported an association between ABO type blood group and cardiovascular (CV) events and outcomes. The precise mechanisms underpinning this striking observation remain unknown, although differences in von Willebrand factor (VWF) plasma levels have been proposed as an explanation...
Autores principales: | Pozder, Carolin, Screever, Elles M., van der Velde, A. Rogier, Silljé, Herman H., Suwijn, Janne, de Rond, Saskia, Kleber, Marcus E., Delgado, Graciela, Schuringa, Jan Jacob, van Gilst, Wiek H., Meijers, Wouter C., März, Winfried, de Boer, Rudolf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002292/ https://www.ncbi.nlm.nih.gov/pubmed/36901846 http://dx.doi.org/10.3390/ijms24054415 |
Ejemplares similares
-
Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis
por: Meijers, Wouter C., et al.
Publicado: (2014) -
ST2 and Galectin-3: Ready for Prime Time?
por: Meijers, Wouter C., et al.
Publicado: (2016) -
Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure
por: van den Berg, Pieter F., et al.
Publicado: (2023) -
Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure
por: Screever, Elles M., et al.
Publicado: (2023) -
Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
por: Yin, Meimei, et al.
Publicado: (2011)